Birdwatch Note
2023-05-31 20:16:34 UTC - NOT_MISLEADING
Although the study is ongoing and is inconclusive if it will serve as a cure, here are some articles that support the claim of doses of Suramin assisting with Autism: https://www.autismparentingmagazine.com/autism-suramin-evolution/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038244/ https://www.europeanpharmaceuticalreview.com/news/164740/iv-suramin-may-be-a-promising-autism-treatment-shows-phase-ii-study/
Written by 1F644347611801D30CBC065E9B1A57F58A2FD7B9A8ADA5349AEBBCA3D7F024F7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1663642230165315585
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1664002952649125889
- noteId - 1664002952649125889
- participantId -
- noteAuthorParticipantId - 1F644347611801D30CBC065E9B1A57F58A2FD7B9A8ADA5349AEBBCA3D7F024F7 Participant Details
- createdAtMillis - 1685564194248
- tweetId - 1663642230165315585
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Although the study is ongoing and is inconclusive if it will serve as a cure, here are some articles that support the claim of doses of Suramin assisting with Autism: https://www.autismparentingmagazine.com/autism-suramin-evolution/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038244/ https://www.europeanpharmaceuticalreview.com/news/164740/iv-suramin-may-be-a-promising-autism-treatment-shows-phase-ii-study/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-05-31 20:16:34 UTC (1685564194248) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-01 02:11:43 UTC (1685585503373) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-05-31 18:52:07 -0500 | Rating Details | |
| 2023-05-31 17:48:47 -0500 | Rating Details | |
| 2023-05-31 17:43:31 -0500 | Rating Details | |
| 2023-05-31 17:16:59 -0500 | Rating Details | |
| 2023-05-31 16:57:02 -0500 | Rating Details | |
| 2023-05-31 16:55:26 -0500 | Rating Details | |
| 2023-05-31 16:38:27 -0500 | Rating Details | |
| 2023-05-31 16:24:32 -0500 | Rating Details | |
| 2023-05-31 15:21:38 -0500 | Rating Details | |
| 2023-05-31 15:20:13 -0500 | Rating Details | |
| 2023-06-01 10:52:55 -0500 | Rating Details | |
| 2023-06-01 01:36:06 -0500 | Rating Details |